Benefit Continues to Accumulate When Treatment is Continued Beyond Plaque Clearance – Estimating Accumulating or Maintained Treatment Benefit in the CLARITY AD and TRAILBLAZER-ALZ2 Trials

Real-world Treatment Patterns and MRI Utilization Among Lecanemab Patients in a Commercial and Medicare Insured Population